GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veritas In Silico Inc (TSE:130A) » Definitions » Asset Turnover

Veritas In Silico (TSE:130A) Asset Turnover : 0.04 (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Veritas In Silico Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Veritas In Silico's Revenue for the three months ended in Jun. 2024 was 円83.8 Mil. Veritas In Silico's Total Assets for the quarter that ended in Jun. 2024 was 円2,404.7 Mil. Therefore, Veritas In Silico's Asset Turnover for the quarter that ended in Jun. 2024 was 0.04.

Asset Turnover is linked to ROE % through Du Pont Formula. Veritas In Silico's annualized ROE % for the quarter that ended in Jun. 2024 was -0.40%. It is also linked to ROA % through Du Pont Formula. Veritas In Silico's annualized ROA % for the quarter that ended in Jun. 2024 was -0.39%.


Veritas In Silico Asset Turnover Historical Data

The historical data trend for Veritas In Silico's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veritas In Silico Asset Turnover Chart

Veritas In Silico Annual Data
Trend Dec21 Dec22 Dec23
Asset Turnover
0.03 0.11 0.22

Veritas In Silico Quarterly Data
Dec21 Dec22 Sep23 Dec23 Mar24 Jun24
Asset Turnover Get a 7-Day Free Trial - - 0.05 0.02 0.04

Competitive Comparison of Veritas In Silico's Asset Turnover

For the Biotechnology subindustry, Veritas In Silico's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Veritas In Silico's Asset Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Veritas In Silico's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Veritas In Silico's Asset Turnover falls into.



Veritas In Silico Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Veritas In Silico's Asset Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=360.356/( (1598.576+1655.531)/ 2 )
=360.356/1627.0535
=0.22

Veritas In Silico's Asset Turnover for the quarter that ended in Jun. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Jun. 2024 )/( (Total Assets (Q: Mar. 2024 )+Total Assets (Q: Jun. 2024 ))/ count )
=83.832/( (2416.24+2393.107)/ 2 )
=83.832/2404.6735
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Veritas In Silico  (TSE:130A) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Veritas In Silico's annulized ROE % for the quarter that ended in Jun. 2024 is

ROE %**(Q: Jun. 2024 )
=Net Income/Total Stockholders Equity
=-9.416/2357.012
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-9.416 / 335.328)*(335.328 / 2404.6735)*(2404.6735/ 2357.012)
=Net Margin %*Asset Turnover*Equity Multiplier
=-2.81 %*0.1394*1.0202
=ROA %*Equity Multiplier
=-0.39 %*1.0202
=-0.40 %

Note: The Net Income data used here is four times the quarterly (Jun. 2024) net income data. The Revenue data used here is four times the quarterly (Jun. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Veritas In Silico's annulized ROA % for the quarter that ended in Jun. 2024 is

ROA %(Q: Jun. 2024 )
=Net Income/Total Assets
=-9.416/2404.6735
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-9.416 / 335.328)*(335.328 / 2404.6735)
=Net Margin %*Asset Turnover
=-2.81 %*0.1394
=-0.39 %

Note: The Net Income data used here is four times the quarterly (Jun. 2024) net income data. The Revenue data used here is four times the quarterly (Jun. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Veritas In Silico Asset Turnover Related Terms

Thank you for viewing the detailed overview of Veritas In Silico's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Veritas In Silico Business Description

Traded in Other Exchanges
N/A
Address
1-11-1, Nishigotanda, Shinagawa-ku, Tokyo, JPN, 141-0031
Veritas In Silico Inc is engaged in discovery of mRNA-targeted small molecule and antisense oligonucleotide drugs. It has ibVIS platform that combines informatics (i) and experimental biology at Veritas In Silico (VIS) that will bring to fruition mRNA-targeted drugs.

Veritas In Silico Headlines

No Headlines